Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (NYSE: EHAB), operating as Enhabit Home Health & Hospice, is a national home health and hospice provider whose activities generate a steady flow of company news and disclosures. As a public company listed on the New York Stock Exchange, Enhabit regularly issues press releases and files Form 8-K reports covering its financial results, strategic updates, leadership developments, and participation in investor conferences.
News about Enhabit often centers on quarterly earnings announcements, where the company reports net service revenue, segment performance for Home Health and Hospice, Adjusted EBITDA, and other financial and operational metrics. These releases highlight trends in home health and hospice admissions, average daily census, patient days, and segment-level profitability, as well as updates on branch openings, de novo locations, and changes in cost per patient day.
Investors following EHAB news will also see regular updates on guidance for net service revenue, Adjusted EBITDA, and Adjusted EPS, along with explanations of non-GAAP financial measures and same-store comparisons. Enhabit’s communications discuss how unusual or nonrecurring items affect its results and how management evaluates core operating performance.
Another key category of Enhabit news involves corporate and governance developments. The company has announced a CEO transition plan, retention awards for senior officers, approval of its 2025 Equity and Incentive Compensation Plan, and voting results from its annual meeting. In addition, Enhabit frequently reports on its participation in healthcare and home care conferences hosted by major financial institutions, where its leadership teams take part in fireside chats and presentations.
For readers tracking EHAB, this news flow provides insight into Enhabit’s home health and hospice operations, financial performance, capital structure, and governance decisions. Monitoring these updates can help contextualize the company’s strategic focus on patient care in the home and its reported progress across its nationwide footprint.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has scheduled its second quarter 2025 earnings conference call for August 7, 2025, at 10:00 AM EDT. The company will release its financial results for the quarter ended June 30, 2025, on August 6, 2025.
The conference call will be accessible via webcast and telephone, with a toll-free number (888-660-6150) and international number (929-203-0843) available for participants. Enhabit currently operates 251 home health locations and 113 hospice locations across 34 states.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. The company's President and CEO Barb Jacobsmeyer and CFO Ryan Solomon will engage in a fireside chat on June 10 at 10 a.m. EDT, which will be available via webcast and replay on the company's investor website.
Enhabit operates across 34 states with 251 home health locations and 113 hospice locations, leveraging advanced technology to deliver patient care in home settings.
Enhabit (NYSE: EHAB) reported its Q1 2025 financial results with net service revenue of $259.9 million and net income of $17.8 million, including a $14.7 million gain on sale of investment. The company achieved Adjusted EBITDA of $26.6 million, up 5.1% year over year.
Key highlights include home health non-Medicare admissions increasing 7.4%, hospice average daily census growing 12.3% year over year, and hospice Adjusted EBITDA rising 64.8%. The company reduced bank debt by $25 million in Q1, bringing the leverage ratio below 4.5 times. Home health faced some challenges with Medicare revenue declining 11%, while hospice segment showed strong performance with 20.5% revenue growth.
Enhabit reaffirmed its 2025 guidance with projected net service revenue of $1,050-$1,080 million and Adjusted EBITDA of $101-$107 million.
Enhabit Inc. (NYSE: EHAB), a national home health and hospice provider, has scheduled its first quarter 2025 earnings release and conference call. The company will announce Q1 2025 results on May 7, 2025, followed by a conference call and webcast on May 8, 2025 at 10 a.m. EDT.
Enhabit operates across 34 states with 255 home health locations and 115 hospice locations. The company specializes in home-based patient care, utilizing advanced technology and clinical teams to deliver healthcare services.
Enhabit Inc. (NYSE: EHAB), a leading home health and hospice provider, has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence from the Institute for Healthcare Improvement (IHI). The recognition highlights Enhabit's implementation of the 4Ms framework: What Matters, Medication, Mentation, and Mobility.
The initiative, led by The John A. Hartford Foundation and IHI in partnership with the American Hospital Association and the Catholic Health Association, focuses on delivering personalized, evidence-based care to older adults. Enhabit's nationwide operations span 255 home health locations and 115 hospice locations across 34 states, implementing a comprehensive care model that emphasizes patient-centered approaches and strengthens relationships between patients and care teams.
Enhabit (NYSE: EHAB) reported its Q4 2024 financial results, showing mixed performance across segments. The company posted net service revenue of $258.2 million but recorded a net loss of $46.0 million, with loss per share of $0.92 and adjusted earnings per share of $0.04.
Key highlights include a 10.7% increase in home health non-Medicare admissions and 48% of non-Medicare visits now in payer innovation contracts at improved rates. The hospice segment showed strong growth with an 8.6% year-over-year increase in average daily census and 6.5% growth in admissions. Hospice net service revenue and Adjusted EBITDA both increased by approximately 13% year-over-year.
The company reduced bank debt by $10 million in Q4, totaling $40 million in debt reduction for 2024. Operational efficiency improved with home office G&A expenses decreasing by 12%. The company expanded its footprint with three new hospice locations in Q4, bringing the 2024 total to one home health and five hospice de novo locations.
Enhabit Home Health & Hospice (NYSE: EHAB) has announced plans to nominate Stephan Rodgers to its Board of Directors at the company's 2025 annual stockholders meeting. Rodgers brings 25 years of executive-level experience, including serving as CEO of AccentCare for over a decade and holding senior positions at UnitedHealth Group.
Rodgers' extensive background includes managing healthcare benefits for GE and service in the U.S. Army Special Forces. Due to non-compete obligations from his AccentCare role, Rodgers will join the board after June 30, 2025, if elected.
Enhabit currently operates 256 home health locations and 112 hospice locations across 34 states, focusing on expanding patient care possibilities in the home setting through advanced technology and clinical teams.
Enhabit (NYSE: EHAB), a national home health and hospice provider, has scheduled its Q4 2024 earnings release for March 5, 2025, followed by a conference call on March 6, 2025, at 10 a.m. EDT. The company operates across 34 states with 256 home health locations and 112 hospice locations.
Investors and interested parties can join the conference call using toll-free number 888-660-6150 or international number 929-203-0843 with Conference ID 5248158. A webcast will be available through the company's investor website.
Enhabit (NYSE: EHAB), a leading national home health and hospice provider, has received the Great Place To Work Certification™ for 2025. The certification is based on current employee feedback, with 83% of employees rating it as a great workplace - 26 points above the U.S. company average.
The company operates across 34 states with 256 home health locations and 112 hospice locations, employing over 10,000 staff. Enhabit offers competitive benefits, flexible schedules, professional development, and advanced technology to support patient care. As one of the largest Medicare-certified providers in the nation, the company focuses on expanding possibilities for home-based patient care.
Encompass Health and Enhabit have won a significant lawsuit in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The Court also ruled against private equity firms Vistria Group and Nautic Partners for aiding these breaches.
The Court found that the defendants misappropriated acquisition opportunities, used confidential information, and recruited key employees while still employed at Encompass Health. As compensation, the Court awarded 43% of VitalCaring Group's profits to Encompass Health and Enhabit, plus $1.62 million in mitigation damages and attorneys' fees.
The defendants were found to have deliberately concealed their actions through falsifying records, deleting evidence, and manipulating communications. The Court's decision sends a clear message about the consequences of breaching fiduciary duties and self-dealing by corporate officers.